Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      If you bought Dollar General® DG™ Health Infants' Pain and Fever Reducer, you may qualify for money relief in a class action settlement


      News provided by

      JND Legal Administration

      Jun 08, 2021, 09:18 ET

      Share this article

      Share this article


      SEATTLE, June 8, 2021 /PRNewswire/ -- JND Legal Administration announces a proposed settlement in a class action lawsuit called Levy v. Dolgencorp, LLC, M.D. Fla., Case No. 3:20-cv-01037-TJC-MCR (the "Settlement"). This notice provides a summary of your rights and options. 

      Para una notificación en español, visite Documentos importantes.

      What is this about?  Plaintiff David Levy claims that Dollar General Corporation; Dolgencorp, LLC; and DG Retail, LLC (collectively, "Defendants" or "Dollar General") used deceptive and misleading sales and marketing tactics in selling the DG Health Infants' Acetaminophen. Dollar General vigorously denies all allegations of wrongdoing or liability made in the lawsuit. Both sides have agreed to the Settlement to avoid the cost of further litigation.

      Who is affected?  You are a Class Member if you purchased DG Health Infants' Acetaminophen from September 15, 2016 through June 8, 2021 (the "Class Period") for personal or household use in the United States.

      What does the Settlement provide?  The Settlement provides both injunctive and monetary relief.

      Injunctive Relief:  Defendants have agreed to not sell DG Health Infants' Acetaminophen unless it states that the liquid medicine in the Product contains the same concentration of liquid acetaminophen that is in DG Health Children's Acetaminophen or language on the labeling/packaging that is substantially similar.

      Monetary Relief:  Defendants also agreed to pay a Settlement Amount of $1.8 million to establish a Claim Fund. The Claim Fund will pay: (1) settlement administration expenses, not to exceed $350,000; (2) attorneys' fees and expenses in the amount approved by the Court, but not to exceed $600,000; (3) a Class Representative service award in an amount of $5,000 as approved by the Court, if any; and (4) monetary benefits to Class Members who timely submit a valid claim.

      What can I get?  If the Court approves the Settlement, Class Members will be entitled to a partial refund of $1.70 for every 1 fl. oz. and 2 fl. oz. bottle of Infants' Acetaminophen purchased during the Class Period for which they have a valid proof of purchase. Class Members without a valid proof of purchase will be entitled to a partial refund of $1.70 for every 1 fl. oz. and 2 fl. oz. bottle of Infants' Acetaminophen for a maximum of 3 units (i.e., a total of up to $5.10 per household). Only one claim can be filed per household.

      If the total amount to be paid for eligible claims exceeds the Claim Fund Balance, then each Class Member's award will be proportionately reduced on a pro rata basis. If the Claim Fund Balance is greater than the total amount to be paid for eligible claims, then each Class Member's award will be proportionately increased on a pro rata basis such that the Claim Fund Balance is exhausted. Any unclaimed checks shall be donated to National Consumer Law Center.

      How do I file a claim?  To receive a cash payment, go to www.DGinfantacetaminophensettlement.com to file or download a Claim Form. You can also write:  DG Infant Acetaminophen Settlement, c/o JND Legal Administration, P.O. Box 91394, Seattle, WA 98111-0050 or email: [email protected]. All Claim Forms must be submitted online or postmarked by August 27, 2021.

      What are my other options?  You can do nothing, exclude yourself, or object to the Settlement.

      Do Nothing: If you do nothing, you will not get a payment and you will give up your right to sue or continue to sue Dollar General for the claims in this case.

      Exclude Yourself: If you exclude yourself or remove yourself from the Class, you will not receive a payment. You will keep your right to sue or continue to sue Dollar General for the claims in this case. Exclusion requests must be postmarked by October 11, 2021. 

      Object: If you do not exclude yourself from the Settlement you may object to it or tell the Court what you don't like about the Settlement. Objections must be postmarked by October 11, 2021.

      For details about your rights and options and how to exclude yourself or object, go to www.DGinfantacetaminophensettlement.com.

      What happens next?  The Court will hold a Final Approval Hearing on October 28, 2021 at 2:00 p.m. ET, in Courtroom 10D at the Bryan Simpson United States Courthouse, 300 North Hogan Street, Jacksonville, Florida 32202, to consider whether to approve the Settlement, Class Counsel's attorneys' fees and expenses, and a Class Representative service award, if any. The Court has appointed Pearson, Simon & Warshaw, LLP, Shamis & Gentile, Edelsberg Law, PA and Dapeer Law, PA as Class Counsel. Class Counsel will answer any questions that the Court may have. You or your attorney may ask to speak at the hearing at your own cost, but you don't have to.

      How do I get more information?  For more information and to view the full notice, go to www.DGinfantacetaminophensettlement.com, or contact the Settlement Administrator by writing DG Infant Acetaminophen Settlement , c/o JND Legal Administration, P.O. Box 91394, Seattle, WA 98111-0050 emailing [email protected], or calling 1-833-722-0894.

      PLEASE DO NOT CONTACT THE COURT OR THE COURT CLERK'S OFFICE

      SOURCE JND Legal Administration

      Modal title

      Also from this source

      Notice of Pendency and Proposed Settlement Involving All Record and Beneficial Holders of dMY Technology Group, Inc. IV ("dMY IV") Class A Common Stock Between December 1, 2021 and December 7, 2021

      /JND Legal Administration-- IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE JULIO MONTEALEGRE and HARRY TRAN, individually on behalf of themselves...

      Johnson Van Kwawegen LLP, Block & Leviton LLP, Labaton Keller Sucharow LLP, and Bernstein Litowitz Berger & Grossmann LLP Announce Notice of Pendency and Proposed Settlement Involving Record Holders and Beneficial Owners of Thoughtworks Holding, Inc. Common Stock

      JND Legal Administration-- IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE IN RE THOUGHTWORKS HOLDING, INC. Consolidated C.A. No. 2024-1295-BWD...

      More Releases From This Source

      Explore

      Retail

      Retail

      Hispanic

      Hispanic

      Legal Issues

      Legal Issues

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.